GHSI Guardion Health Sciences
- 8.2250
- +0.1400+1.73%
- 8.4756
- +0.2506+3.05%
Guardion Health Sciences News
Stocks that moved the day before part 1 e-Guardian, Insource, Charm Care, etc.
<コード>Stock name 8-day closing price ⇒ compared to the previous day Yusen ＜9101＞ 4480 +175 stock repurchase announcement with an upper limit of 7.6% of the number of issued shares. AGC＜5201＞ 5244-592 1st quarter operating profit decreased by 29.5%. Toyota ＜7203＞ 3579 - operating profit for the fiscal year ending 2025/3 is expected to decrease 19.7%. Stock buybacks and cancellations were also announced. Stock prices don't have a sense of direction. LINTEC ＜7966＞ 3450 +26025 operating profit for the fiscal year ending March 31 is expected to increase 69.4%. Shinnichi Kagaku <239
eGuardian --- Changes in dividend policy, revisions to year-end dividend forecasts for the fiscal year ending 2024/9, and establishment of a new shareholder benefit program
E-Guardian ＜6050＞ announced changes in dividend policy, revisions to year-end dividend forecasts for the fiscal year ending 2024/9, and establishment of a new shareholder benefit system on the 7th. The company will make decisions to increase the dividend payout ratio, make a basic policy of allocating profits according to business results, and change to paying dividends using a consolidated dividend ratio of about 30% as a guide. Along with that, the year-end dividend forecast for the fiscal year ending 2024/9 will be revised upward to 31 yen, an increase of 4 yen from the previous forecast. The company will increase the attractiveness of investing in the company's shares and make the medium to long term more people
E-Guardian -- Announces Year-End Dividend Increase Despite 2Q Decline in Sales
E-Guardian ＜6050＞ announced consolidated financial results for the 2nd quarter (23/10/24 to 3/24) of the fiscal year ending 2024/9 on the 7th. Net sales decreased 7.0% from the same period last year to 5.718 billion yen, operating profit fell 6.6% to 888 million yen, ordinary profit fell 9.2% to 872 million yen, and quarterly net profit attributable to parent company shareholders fell 18.0% to 536 million yen. Social support sales decreased 6.2% from the same period last year to 3,317 billion yen. Cumulative period for this 2nd quarter
Guardion Health Sciences Updates Executive Compensation Plans
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell sharply during Tuesday's session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free cas
Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals Among Healthcare Movers
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
Shares of Biophytis S.A. (NASDAQ:BPTS) rose sharply in today's pre-market trading after reporting FY23 results. Biophytis posted a FY23 loss of €0.03 per share, versus a year-ago loss of €0.14 per s
Guardion Health Sciences Files to Sell 690,100 Shares of Common Stock
Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching
Guardion Health Sciences 2023 Rev $12.2M >GHSI
Guardion Health Sciences 2023 Rev $12.2M >GHSI
Guardion Health Sciences 2023 EPS 12c >GHSI
Guardion Health Sciences 2023 EPS 12c >GHSI
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
Viactiv Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022 HOUSTON, TEXAS,
PRSO, AKRO and MIRA Among Pre-market Losers
Guardion Health Sciences Cut to Hold From Buy by Maxim Group
Guardion Health Sciences Cut to Hold From Buy by Maxim Group
Express News | Maxim Group Downgrades Guardion Health Sciences to Hold
Guardion Health Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 02/02/2024 — Maxim Group Downgrades Buy → Hold 07/18/2022 -90.93% Ascendiant Capital → $0.75 Initiates Co
IFBD, BFRG and GHSI Among Pre-market Losers
Investors Still Aren't Entirely Convinced By Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues Despite 53% Price Jump
Guardion Health Sciences, Inc. (NASDAQ:GHSI) shareholders would be excited to see that the share price has had a great month, posting a 53% gain and recovering from prior weakness.
Trending Stocks Today: Connexa Sports Technologies Surges 108.09%
January 31st - US stocks trending in regular trading hours.Gainers: $Connexa Sports Technologies(CNXA.US)$ surges 108.09% to $0.41 with a turnover of $117.82 million. $Minim(MINM.US)$ shoots up 60.53%
Why Guardion Health Sciences Stock Is Up Today
Guardion Health Sciences, Inc. (NASDAQ:GHSI) shares are trading higher Wednesday after the company announced it has signed an equity purchase agreement to sell its Activ Nutritional, LLC subsidiary, w
Analysis
Price Target
No Data
